212 related articles for article (PubMed ID: 12766880)
1. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
Jacobson PA; Ng J; Green KG; Rogosheske J; Brundage R
Biol Blood Marrow Transplant; 2003 May; 9(5):304-11. PubMed ID: 12766880
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic study of cyclosporine in the hematopoietic stem cell transplant recipients.
Zhou Y; Sheng XY; Xu JY; Bi SS; Lu W; Cui YM
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):568-75. PubMed ID: 23611568
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.
Eljebari H; Gaies E; Fradj NB; Jebabli N; Salouage I; Trabelsi S; Lakhal M; Klouz A
Eur J Clin Pharmacol; 2012 Nov; 68(11):1517-24. PubMed ID: 22527344
[TBL] [Abstract][Full Text] [Related]
6. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM
Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms.
Kim MG; Kim IW; Choi B; Han N; Yun HY; Park S; Oh JM
Ann Pharmacother; 2015 Jun; 49(6):622-30. PubMed ID: 25818517
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
Li TF; Hu L; Ma XL; Huang L; Liu XM; Luo XX; Feng WY; Wu CF
Acta Pharmacol Sin; 2019 Dec; 40(12):1603-1610. PubMed ID: 31341257
[TBL] [Abstract][Full Text] [Related]
9. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
Xue L; Zhang WW; Ding XL; Zhang JJ; Bao JA; Miao LY
Am J Med Sci; 2014 Dec; 348(6):448-54. PubMed ID: 25247760
[TBL] [Abstract][Full Text] [Related]
11. Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.
Dupuis LL; Seto W; Teuffel O; Gibson P; Schultz KR; Doyle JD; Gassas A; Egeler RM; Sung L; Schechter T
Biol Blood Marrow Transplant; 2013 Mar; 19(3):418-23. PubMed ID: 23128321
[TBL] [Abstract][Full Text] [Related]
12. Assessment of converting from intravenous to oral administration of cyclosporin A in pediatric allogeneic hematopoietic stem cell transplant recipients.
Choi JS; Lee SH; Chung SJ; Yoo KH; Sung KW; Koo HH
Bone Marrow Transplant; 2006 Jul; 38(1):29-35. PubMed ID: 16715103
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of cyclosporine a conversion from twice-daily infusion to oral administration in allogeneic hematopoietic stem cell transplantation.
Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Kato M; Sakai H; Takahashi M; Miura I
Am J Ther; 2014; 21(5):377-84. PubMed ID: 23011175
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipients.
Rosenbaum SE; Baheti G; Trull AK; Akhlaghi F
Ther Drug Monit; 2005 Apr; 27(2):116-22. PubMed ID: 15795639
[TBL] [Abstract][Full Text] [Related]
15. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
[TBL] [Abstract][Full Text] [Related]
16. Determination of initial i.v. CYA dosage to achieve target AUC values in pediatric hematopoietic stem cell transplant patients.
Jin M; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
Bone Marrow Transplant; 2008 Oct; 42(7):455-9. PubMed ID: 18622423
[TBL] [Abstract][Full Text] [Related]
17. Initial dosage optimisation of cyclosporine in Chinese paediatric patients undergoing allogeneic haematopoietic stem cell transplantation based on population pharmacokinetics: a retrospective study.
Feng H; Wang X; Zheng W; Liu S; Jiang H; Lin Y; Qiu H; Chan TF; Huang M; Li Y; Mo X; Li J
BMJ Paediatr Open; 2023 Aug; 7(1):. PubMed ID: 37643815
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cyclosporine A at a high-peak concentration of twice-daily infusion and oral administration in allogeneic haematopoietic stem cell transplantation.
Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Shibuya Y; Kato M; Takahashi M; Miura I
J Clin Pharm Ther; 2011 Aug; 36(4):518-24. PubMed ID: 21105879
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation.
Fernandez HF; Tran HT; Albrecht F; Lennon S; Caldera H; Goodman MS
Biol Blood Marrow Transplant; 2002; 8(9):486-92. PubMed ID: 12374453
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance.
Ling J; Yang XP; Dong LL; Jiang Y; Zou SL; Hu N; Chen R
J Clin Pharm Ther; 2022 Apr; 47(4):483-492. PubMed ID: 34779003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
